Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Pharmaceuticals
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
UnitedHealth Group (UNH) Earnings in Q4 2025
UnitedHealth Group Inc. signs on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday,…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Novo Nordisk and Pfizer executives weigh in
US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…
Novo Nordisk shares rise after launch of anti-obesity pill Wegovy
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, on January 15, 2026. George Frey…
Novo Nordisk's first GLP-1 obesity pill launched in the US
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, outside Copenhagen, on November…
Shares of Novo Nordisk, maker of Wegovy, rise after approval of GLP-1 pill
Novo Nordisk shares rose more than 7% on Tuesday after the Wegovy maker secured approval for its GLP-1 pill, a…
Nine pharmaceutical companies sign agreements with Trump to lower drug prices
US President Donald Trump speaks during an event in the Roosevelt Room of the White House on December 19, 2025…
Pfizer's 2026 guidance shows deals with Metsera and Seagen will take time to bear fruit
Smith Collection | Stock Photos | fake images Pfizer It forecast modest guidance for 2026 on Tuesday as it looks…